您的位置: 首页 > 农业专利 > 详情页

Use of high dose pridopidine for treating Huntingtons disease
专利权人:
Teva Pharmaceuticals International GmbH
发明人:
Bassan, Merav,Eyal, Eli,Hagai, Esther Lukasiewicz,Sveinsdotter Teige Wickenberg, Anna Kristina
申请号:
AU2014281414
公开号:
AU2014281414A1
申请日:
2014.06.19
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
This invention provides a method of treating a human patient afflicted with Huntingtons disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof such that greater than 135 mg of pridopidine is administered to the patient per day. This invention further provides a method of treating a human patient afflicted with Huntingtons disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine hydrochloride such that greater than 90 mg of pridopidine is administered to the patient per day.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充